皓宸医疗
(002622)
| 流通市值：18.90亿 | | | 总市值：18.90亿 |
| 流通股本：8.40亿 | | | 总股本：8.40亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 314,060,723.5 | 134,804,640.83 | 702,897,591.79 | 526,891,688.79 |
| 营业总成本 | 319,756,039.49 | 145,564,795.01 | 766,396,075.56 | 557,460,141.75 |
| 其他经营收益 | | | | |
| 营业利润 | -1,959,937.32 | -7,560,183.59 | -111,580,165.82 | -19,672,693.9 |
| 利润总额 | -2,411,657.27 | -7,694,672.98 | -125,918,519.68 | -28,257,351.48 |
| 净利润 | -5,345,448.14 | -8,648,208.88 | -129,925,274 | -31,025,238.07 |
| 每股收益 | | | | |
| 其他综合收益 | 4,255,971.08 | 4,256,010.48 | -6,793,700.91 | -7,265,883.57 |
| 综合收益总额 | -1,089,477.06 | -4,392,198.4 | -136,718,974.91 | -38,291,121.64 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 256,616,626.14 | 256,778,550.07 | 262,110,944.83 | 272,568,592.33 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,075,593,131.74 | 1,090,868,622.75 | 1,095,911,636.06 | 1,181,119,602.6 |
| 资产总计 | 1,332,209,757.88 | 1,347,647,172.82 | 1,358,022,580.89 | 1,453,688,194.93 |
| 流动负债: | | | | |
| 流动负债合计 | 887,680,389.08 | 899,384,328.29 | 903,943,985.1 | 885,303,770.09 |
| 非流动负债: | | | | |
| 非流动负债合计 | 134,012,004.69 | 141,048,201.77 | 142,471,754.62 | 157,258,252.27 |
| 负债合计 | 1,021,692,393.77 | 1,040,432,530.06 | 1,046,415,739.72 | 1,042,562,022.36 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 260,957,591.31 | 267,441,708.91 | 270,727,544.03 | 364,359,479.58 |
| 股东权益合计 | 310,517,364.11 | 307,214,642.76 | 311,606,841.17 | 411,126,172.57 |
| 负债和股东权益合计 | 1,332,209,757.88 | 1,347,647,172.82 | 1,358,022,580.89 | 1,453,688,194.93 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 328,073,069.01 | 150,959,546 | 714,310,142.27 | 530,764,205.46 |
| 经营活动现金流出小计 | 317,641,194.4 | 147,673,795.37 | 648,295,218.93 | 540,910,397.34 |
| 经营活动产生的现金流量净额 | 10,431,874.61 | 3,285,750.63 | 66,014,923.34 | -10,146,191.88 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 481.2 | - | 255,000 | - |
| 投资活动现金流出小计 | 1,276,693.3 | 405,678.71 | 21,896,677.86 | 4,981,030.22 |
| 投资活动产生的现金流量净额 | -1,276,212.1 | -405,678.71 | -21,641,677.86 | -4,981,030.22 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 77,900,000 | - | 8,330,000 | 8,330,000 |
| 筹资活动现金流出小计 | 84,672,676.66 | 3,424,149.97 | 62,761,842.98 | 14,487,189.81 |
| 筹资活动产生的现金流量净额 | -6,772,676.66 | -3,424,149.97 | -54,431,842.98 | -6,157,189.81 |
| 汇率变动对现金及现金等价物的影响 | -108.18 | -68.78 | -21.9 | 13.85 |
| 现金及现金等价物净增加额 | 2,382,877.67 | -544,146.83 | -10,058,619.4 | -21,284,398.06 |
| 期末现金及现金等价物余额 | 123,895,065.46 | 120,968,041.86 | 121,512,187.79 | 110,286,409.13 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 2,382,877.67 | - | -10,058,619.4 | - |